NCT00036387View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.

PHASE3CompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2003

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY

NCT00036387 - A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis. | Biotech Hunter | Biotech Hunter